Considerations for the Development, Scale-up and Manufacturing of mRNA Therapeutics

Considerations for the Development, Scale-up and Manufacturing of mRNA Therapeutics

Poster Zone

Information

Recently, there has been significant interest in the use of messenger RNA (mRNA) as an ex vivo and in vivo therapeutic. Since mRNA is expressed in the cytoplasm it may be particularly useful for improving gene expression in difficult-to-transfect non-dividing cells.

Title

Link to Poster
https://www.trilinkbiotech.com/media/contentmanager/content/mRNA_WVC3.pdf
TriLink BioTechnologiesTriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO for overcoming challenges in the synthesis and scale-up of nucleic acids,NTPs and mRNA, including its proprietary CleanCap® mRNA capping technology. TriLink offers cGMP and general mRNA, oligonucleotide & plasmid manufacturing to support therapeutic, vaccine and diagnostic customers.  

Log in